News Quantified

HAE – haemonetics corporation (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

Haemonetics Receives FDA Clearance for NexSys® PCS Plasma Collection System with Persona® PLUS Technology

Haemonetics to Present at Raymond James 47th Annual Institutional Investors Conference

Haemonetics Corporation (HAE) Q3 Performance Prompts Baird Model Update, Price Target Falls to $81 [Yahoo! Finance]

Chuck Royce's Strategic Moves: Significant Reduction in Haemonetics Corp [Yahoo! Finance]

Haemonetics (NYSE:HAE) was given a new $81.00 price target on by analysts at Robert W. Baird.

-2.8%

BEAT

-8.7%

BEAT

-1.3%

BEAT

3.1%

BEAT

Form SCHEDULE 13G HAEMONETICS CORP Filed by: AQR CAPITAL MANAGEMENT LLC

Form 8-K HAEMONETICS CORP For: Feb 12

Form 8-K HAEMONETICS CORP For: Feb 05

Form 10-Q HAEMONETICS CORP For: Dec 27

Form 8-K HAEMONETICS CORP For: Jan 09

Top News Gainers

8/6 Q1/2020 6/29/2019 EPS 0.810 ZacksConsensus 0.630 ActVsEst 0.180 - Beat 12.0%

2/4 Q3/2020 12/28/2019 EPS 0.940 ZacksConsensus 0.760 ActVsEst 0.180 - Beat 9.5%

4/2 Haemonetics Acquires enicor GmbH to Expand Advanced Viscoelastic Testing Portfolio 8.9%

11/1 Q2/2020 9/28/2019 EPS 0.870 ZacksConsensus 0.720 ActVsEst 0.150 - Beat 7.2%

2/5 Haemonetics Co. (NYSE: HAE) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $142.00 price target on the stock. 7.2%

5/13 Form 5 HAEMONETICS CORP For: Mar 30 Filed by: KROLL MARK W 5.8%

4/13 Form 4 HAEMONETICS CORP For: Apr 09 Filed by: KROLL MARK W 5.1%

4/17 Michael Coyle Joins Haemonetics Board of Directors 4.7%

5/7 Q4/2019 3/30/2019 EPS 0.610 ZacksConsensus 0.550 ActVsEst 0.060 - Beat 4.4%

8/12 Form 4 HAEMONETICS CORP For: Aug 09 Filed by: Goldstein Dan 3.2%

Top News Decliners

4/7 Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Raymond James from $150.00 to $130.00. They now have an "outperform" rating on the stock. -8.2%

11/2 Haemonetics (HAE) Q2 2020 Earnings Call Transcript [The Motley Fool] -6.5%

1/23 Haemonetics Co. (NYSE: HAE) had its price target lowered by analysts at Raymond James from $150.00 to $145.00. They now have an "outperform" rating on the stock. -4.8%

5/22 Form 10-K HAEMONETICS CORP For: Mar 30 -3.3%

3/30 Haemonetics Appoints Anila Lingamneni Executive Vice President, Chief Technology Officer -2.8%

5/11 Haemonetics Corporation (HAE) CEO Chris Simon on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] -2.7%

5/24 Form 4 HAEMONETICS CORP For: May 22 Filed by: Simon, Christopher -2.6%

9/3 Form 4 HAEMONETICS CORP For: Aug 30 Filed by: Bolorforosh Said -2.1%

2/4 Form 10-Q HAEMONETICS CORP For: Dec 28 -2.0%

9/9 Form 4 HAEMONETICS CORP For: Sep 05 Filed by: Llorens Josep -1.7%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day